BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1081010)

  • 1. [Factor VIII-like antigen in haemophilia A and in Willebrand's disease (author's transl)].
    Blatný J; Procházka J; Bártová A; Fischerová E; Slepicka L; Skodová M
    Cas Lek Cesk; 1975 Sep; 114(38):1174-6. PubMed ID: 1081010
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enzyme immunoassay of factor VIII-related antigen with observation in patients with von Willebrand's disease and hemophilia A (author's transl)].
    Okuda T; Masuyama H; Tanigawa T; Narihiro N; Fujimura Y; Takase T; Mikami S; Yoshioka A; Fukui H
    Rinsho Ketsueki; 1980 Jul; 21(7):946-52. PubMed ID: 6775115
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of von Willebrand's disease by means of the quantitative immunological assay of factor VIII-related antigen (author's transl)].
    Gruson R; Kernoff PB
    Dtsch Med Wochenschr; 1974 Aug; 99(31):1593-5. PubMed ID: 4210557
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laser nephelometry of factor VIII-related antigen with observation in patients with von Willebrand'd disease and hemophilia A (author's transl)].
    Okuda T; Masuyama H; Matsuoka H; Tsukada S
    Rinsho Byori; 1981 Sep; 29(9):939-44. PubMed ID: 6799672
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological half-time of factor VIII antigen (antihemophilic globulin) in hemophilia A and in von Willebrand's disease].
    Uszyński L
    Acta Haematol Pol; 1974; 5(3):189-94. PubMed ID: 4546992
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of immunological techniques to the study of classic haemophilia and von Willebrand's disease.
    Bennett B
    Br J Haematol; 1973 Aug; 25(2):273-4. PubMed ID: 4580214
    [No Abstract]   [Full Text] [Related]  

  • 9. [Von Willebrand's disease (author's transl)].
    Jacky E; Blättler W; Müller M
    Ther Umsch; 1979 Apr; 36(4):341-4. PubMed ID: 377558
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
    Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
    Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of the human factor VIII/von Willebrand's factor protein I. Comparison of the protein found in normal, von Willebrand's disease and hemophilia A.
    Gralnick HR; Coller BS; Marchesi SL
    Thromb Res; 1975 Feb; 6(2):93-108. PubMed ID: 803726
    [No Abstract]   [Full Text] [Related]  

  • 12. [Von Willebrand's disease. Studies on platelet function, ristocetin induced platelet aggregation and factor VIII related antigen (author's transl)].
    Mimaya J; Nagao T; Iizuka A; Yamashita H
    Rinsho Ketsueki; 1975 Aug; 16(8):775-84. PubMed ID: 1081150
    [No Abstract]   [Full Text] [Related]  

  • 13. [Major HLA histocompatibility system as a possible genetic marker in haemophilia A and Von Willebrand's disease (author's transl)].
    Ustariz CR; Arce S; Almaguer M; Almagro D; Hernández P; Ballester JM; Pérez S; Corral JF
    Sangre (Barc); 1978; 23(3):314-9. PubMed ID: 307822
    [No Abstract]   [Full Text] [Related]  

  • 14. [An assessment of the quotient F. VIII-procoagulant/F. VIII-antigen in haemophilia A carriers. Evaluation of the diagnosis of the carrier state (author's transl)].
    Aznar JA; Tascón A; Luño E; Rafecas FJ; Marty ML
    Sangre (Barc); 1977; 22(5):533-40. PubMed ID: 302993
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on molecular size distribution of factor VIII-related antigen in patients with Von Willebrand's disease and their parents].
    Mikami S; Nishino M; Yasui M; Okubo Y; Shima H; Fukui H
    Rinsho Ketsueki; 1982 Aug; 23(8):1198-204. PubMed ID: 6815349
    [No Abstract]   [Full Text] [Related]  

  • 18. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor VIII-related antigen in canine hemophilia and Von Willebrand's disease: Variation when measured with different agaroses.
    Benson RE; Bouma BN; Dodds WJ
    Thromb Res; 1975 Sep; 7(3):383-9. PubMed ID: 1081282
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
    Gamba G; Grignani G; Nicolini E; Ascari E
    Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.